Dr Ronald Delanois | Hip Surgeon Baltimore | Shoulder Surgeon Owings Mills

Ronald E. Delanois, M.D.

Board-Certified & Fellowship-Trained Orthopedic Surgeon

Ronald E. Delanois, M.D., F.A.A.O.S., is a board-certified, fellowship-trained orthopedic surgeon who has more than 20 years of experience with complex hip, knee and shoulder reconstructive surgery.

He serves as the Jerome P. Reichmister, M.D., Endowed Chairman of Orthopedics for the Rubin Institute for Advanced Orthopedics, the division director of the Center for Joint Preservation and Replacement, the director of Hip, Knee and Shoulder Surgery, and also the director of the Research Division and Research Fellowship Program.

His emphasis is on diagnostic, arthroscopic and joint preserving procedures for the hip, knee and shoulder. Dr. Delanois and his team deliver advanced orthopedic solutions to patients who suffer from a multitude of joint ailments.

He has performed thousands of arthroscopic and reconstructive procedures. He is involved with the latest cutting-edge technology that allows the patient to return to a full and active lifestyle in the shortest amount of time.

Philosophy of Care

Dr. Delanois believes in conservative management as a first line of defense whenever possible. This involves educating patients and their families on nonsurgical as well as surgical techniques available, oral medication, injections and physical therapy.

When surgery is indicated, Dr. Delanois believes in performing joint-preserving procedures first. This allows the patient a faster recovery as well as a quicker return to a normal life.

Dr. Delanois currently holds an academic appointment at USUHS, Bethesda, as a clinical assistant professor of surgery. He is an active member in the Society of Military Orthopedic Surgeons. He sits on the American Academy of Orthopaedic Surgeons Political Action Committee, which represents orthopedic surgeons before members of Congress. He serves on the board of the Maryland Orthopaedic Association and on the Board of Councilors for the American Academy of Orthopaedic Surgeons.

He served 24 years in the United States Air Force; for eight years he was the division head of the Adult Reconstructive Service at the Naval Medical Center Portsmouth.

He participates as a volunteer surgeon during mission trips to Haiti to help those with orthopedic problems.

Dr. Delanois lives in Lutherville, Maryland, with his wife and their three children. He is an outdoor enthusiast and enjoys activities such as competitive cycling and aerobics. He is an avid collector of fine writing instruments and enjoys spending time with his family.

Education

Dr. Delanois obtained his medical degree from the Uniformed Services University of the Health Sciences (USUHS). He then did his orthopedic training in the Air Force at Wilford Hall Medical Center in San Antonio, Texas. He received his fellowship training in hip and knee replacement surgery under the mentorship of Drs. Mont and Hungerford at The Johns Hopkins Medical Institutions.

Medical Education: Uniformed Services Univ. of the Health Sciences
Internship: Wilford Hall Air Force Medical Center
Fellowship: The Johns Hopkins Hospital
Residency: Wilford Hall Air Force Medical Center
Membership: Dr. Delanois is a member of The Hip Society and The Knee Society

Areas of Interest

Dr. Delanois’ area of experience is with complex hip, knee and shoulder reconstructive surgery. He specializes in the diagnostic, arthroscopic and joint restoration procedures for these joints.

He is particularly interested in focal cartilage loss. In the hip, he employs the technique of hip arthroscopy for the diagnosis and treatment of hip pain. In the knee, he uses techniques such as high tibial osteotomies, unicompartmental knee replacements and cartilage transplantation.

His current research interests include osteonecrosis, joint restoration techniques and the improvement of wear in hip and shoulder replacements.

Clinical Research

A Phase 1b Open-Label, Dose-Escalating Study to Evaluate the Safety and Tolerability of PLG0206 in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA); Peptilogics, Inc. Total Contract Value: $116,652.
Comparative evaluation of the performance and safety of A-CP HA Kit, for the preparation of a combination of platelet rich plasma and hyaluronic acid versus hyaluronic acid alone and placebo in patients with knee osteoarthritis; Regen Lab USA. Total Contract Value: $424,685.
The Efficacy of Platelet Rich Plasma Compared with Corticosteroid Injections for the Treatment of Pain Associated with Knee Osteoarthritis; Sinai Hospital of Baltimore, Inc. Internally Funded Research.
A Phase 3 Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy of Amniotic Suspension Allograft (ASA) in Patients with Osteoarthritis of the Knee; Organogenesis Inc. Total Contract Value: $549,874.
A Randomized Controlled Trial Evaluating Edema and ROM Using Negative Pressure Therapy Over Closed Incisions and Surrounding Soft Tissue Versus Standard Surgical Dressings in Bilateral Total Knee Arthroplasty: A Pilot Study (The ENABLE Trial); KCI Manufacturing Unlimited Company/3M. Total Contract Value: $138,164.
Multi-Center Clinical Investigation of the ATTUNE® Cementless Fixed Bearing Tibial Base and Cementless Patella Implants in Total Knee Arthroplasty; DePuy Orthopaedics, Inc. Total Contract Value: $314,415.
A Phase 1, Double-Blind, Single Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Activity of TRL1068 in Subjects with Prosthetic Joint Infection of the Knee or Hip and Undergoing Primary Two-Stage Exchange Arthroplasty; Trellis Bioscience LLC. Total Contract Value: $361,610.
The Pericapsular Nerve Block in Total Hip Arthroplasty: A Randomized, Controlled Trial; Rubin Institute for Advanced Orthopedics, Sinai Hospital of Baltimore, Inc. Internally Funded.
Prospective Functional, Gait, and Outcome Comparison Study of Medial Pivot versus Single Radius Design for Total Knee Arthroplasty; MicroPort Orthopedics. Total Contract Value: $650,000.
Comparison of Alignment achieved using the VELYS Robotic-Assisted Solution versus Manual Instrumentation in Total Knee Arthroplasty: A Prospective, Non-Randomized Multi-Center post-market Clinical Investigation; DePuy Orthopaedics, Inc. Total Contract Value: $207,373.
Perioperative Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty: A prospective, randomized, open-label, controlled multi-center trial; American Association of Hip and Knee Surgeons (AAHKS).
A randomized, sham controlled, double-blind, multi-center study of Neuromuscular Electrical Stimulation (NMES) as an Adjunctive Therapy for Knee Pain Relief and Improving Functional Outcomes in Knee Osteoarthritis (OA) Patients; Cymedica Orthopedics, Inc. Total Contract Value: $174,745.
Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears; Orthofix, Inc. Total Contract Value: $975,050.
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee; Kolon TissueGene, Inc. Total Contract Value: $600,891.
Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System – “U-Propel Study”; United Orthopedic Corporation. Total Contract Value: $333,300.
Post-Approval Study of the R3™ Biolox® delta Ceramic Acetabular System – United States; Smith & Nephew, Inc. Total Contract Value: $276,069.
Osteoporosis-Related Post-Fracture Care Application Development and Testing; Premier, Inc. Total Contract Value: $85,000.
A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis; Flexion Therapeutics. Total Contract Value: $125,014.
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, Designed to Determine the Efficacy, Safety, and Tolerability of Intramuscular Administration of Allogeneic PLX-PAD Cells for the Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF); Pluristem Ltd. Total Contract Value: $109,367.
Clinical Survivorship and Outcomes of X3 Polyethylene in Total Knee Arthroplasty at Minimum 10 Years Follow-Up; Howmedica Osteonics Corp. Total Contract Value: $67,145.
In Vivo Wear Analysis of 3.9 Millimeter X3 Polyethylene Liners in Total Hip Arthroplasty at Minimum 10 Years Follow-Up; Howmedica Osteonics Corp. Total Contract Value: $105,820.
Mid-Term Clinical Performance of the Accolade II Stem; Howmedica Osteonics Corp. Total Contract Value: $53,785.
A Prospective, Randomized, Double-Blind, Placebo Controlled Feasibility Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee; Orthofix, Inc. Total Contract Value: $1,351,625.
A Multicenter, Randomized, Double-Blind, Controlled Trial Comparing Local Infiltration Analgesia with EXPAREL to Local Infiltration Analgesia without EXPAREL to Manage Postsurgical Pain Following Total Knee Arthroplasty; Pacira Pharmaceuticals, Inc.
A prospective, post-market, multi-center study of the outcomes of the Triathlon Titanium Knee System; Stryker Orthopaedics. Total Contract Value: $77,900.
Long-Term Safety Follow-Up of Study Subjects Who Were Previously Enrolled in a TissueGene Clinical Trial and Were Administered TissueGene-C; TissueGene, Inc. Total Contract Value: $115,000.
Clinical Validation of CD Diagnostics Synovasure PJI ELISA Test and Synovasure PJI Lateral Flow Test for Detection of Periprosthetic Joint Infection (PJI) in Synovial Fluid; CD Diagnostics/Zimmer Biomet

Publications

Click here to download Dr. Delanois’ CV